Psychoactive effects of GH001 in patients with treatment-resistant depression: results from a phase 2b, double-blind, randomised controlled trial

Neuroscience Applied 2026 Open access

Read full text
Authors: F. Devlin, B.T. Baune, N. Cardoner, W.J. Cubała, K. Doolin, RM Dueñas Herrero, M. Elices, K. Jakuszkowiak-Wojten, L. Janů, J.R. Kelly, R. MacIssac, S.J. McInerney
+10 more A. Nawka, T. Páleníček, V. Perez Sola, Andreas Reif, CB Svendsen, C. Sweeney, M.E. Thase, V. Valcheva, Eduard Vieta, J.G. Ramaekers
DOI: 10.1016/j.nsa.2025.106392
Cited by: 1

Fields of Study & Subjects

Neurotransmitter Receptor Influence on Behavior Stress Responses and Cortisol Treatment of Major Depression

Publication details

Journal / source
Neuroscience Applied
Publisher
Elsevier BV
Volume
5
Pages
106392–106392
Publication date
1 January 2026
Language
EN